source
- UK issues AI-in-medicine regulatory recommendations; FDA pauses new enrollment in Biohaven epilepsy trialsThe United Kingdom has released a set of recommendations aimed at governing the use of artificial intelligence in medical applications. The guidance outlines how AI tools should be evaluated and mo…
- FDA signals openness to innovative approaches for psychedelic drug developmentFDA officials said the agency is open to novel, innovative approaches to the clinical development of psychedelic drugs, citing the worsening mental health crisis in the United States. The agency’s…